Study | Exclusion reasons | Remarks | Reference(s) | ||
---|---|---|---|---|---|
Elgazzar, 0 | - | preprint withdrew on 14 July 2021 due to verifiable concerns (https://grftr.news/why-was-a-major-study-on-ivermectin-for-covid-19-just-retracted/) | |||
NCT04425850 (Caravallo), 2020 | non randomized controlled trial |
Caravallo HE Journal of Biomedical Research and Clinical Investigation https://doi.org/10.31546/2633-8653.1007 |
|||
Patel, 2020 | prospective cohort | cancelled by investigator | Surgisphere corporation : retracted publication | ||
Morgenstern, 2020 | single-arm | no control group |
Morgenstern J medRxiv https://doi.org/10.1101/2020.10.29.20222505 |
||
Hazan, 2021 | case series | no control group |
Hazan S et al. medrxiv;2021.07.06.21259924v1 10.1101/2021.07.06.21259924 |
||
IDEA, 2020 | prospective cohort | no control group |
Carvallo H medRxiv https://doi.org/10.1101/2020.09.10.20191619 |
||
Chamie-Quintero,, 2020 | population based cohort retrospective | no control group | No statistical analyses just a comparison of death between several peruvian states with or without mass distribution of ivermectin | ||
Nasir, 2020 | non randomized controlled trial | no clinically relevant endpoint | |||
Nasir, 2020 | non randomized controlled trial | no clinically relevant endpoint | |||
Elgazzar - prophylaxis, 2020 | randomized controlled trial | other | withdrawal of the publication | ||
Samaha, 2021 | randomized controlled trial | other | withdrawal of the publication | ||
Niaee (vs placebo), 2020 | randomized controlled trial | other | On 8 October 2021 and 9 October 2021, two articles were published by subject-matter experts outlining concerns about various aspects of the study and, in particular, calling into question the randomization of participants. The authors and publishing journal have been alerted to these issues, and this note will be updated with any new information related to the publication. |
Niaee MS et al. researchsquare 10.21203/rs.3.rs-109670/v1 Niaee MS et al. Asian Pacific Journal of Tropical Medicine 10.4103/1995-7645.318304 |
|
Cadegiani -Iver, 2020 | observational study | other | unappropriated control group |
Cadegiani FA medrxiv https://doi.org/10.1101/2020.10.31.20223883 |
|
IFORS (Pott-Junior), 2020 | randomized controlled trial | other | The article has been retracted by Toxicology Reports |
Pott-Junior H Toxicol Rep 2021;8:505-510. 10.1016/j.toxrep.2021.03.003 |
|
Elgazzar - treatment, 2020 | randomized controlled trial | other | withdrawal of the publication |